09.00 – 09.30 Opening Remarks
09.30 – 11.00 Changing Nature Of Headache Practice
Aynur ÖZGE, Betül BAYKAN
09.30 – 09.45 Real Time Telemedicine – Based Headache History
Paolo MARTELLETTI
09.45 – 10.00 Telemedicine Based Headache Diagnosis
Cristina TASSORELLI
10.00 – 10.15 Transition From Traditional To Telemedicine Headache Practice
Peter GOADSBY
10.15 – 11.00 Discussion
Messoud ASHINA, Zaza KATSARAVA
11.00 – 11.30 Coffee Break
11.30 – 13.00 COVID-19 Headache
Hayrunnisa BOLAY, Fayyaz AHMED
11.30 – 11.45 Clinical Manifestations And Management Of Headache in COVID-19
Ömer KARADAŞ
11.45 – 12.00 Diagnostic Criteria For COVID-19 Headache
Betül BAYKAN
12.00 – 12.15 The Role Of Inflammation In COVID-19 Headache
Hayrunnisa BOLAY
12.15 – 12.30 Neuroinflammatory Mediators in Headache
Hülya Karataş KURŞUN
12.30 – 13.00 Discussion
Patricia Pozo ROSICH, Ramez Reda MOUSTAFA
13.00 – 14.00 Oral Presentations
Okan BÖLÜKBAŞI, Arife Çimen ATALAR
13.00 – 13.05 Mehmet TÖNGE, OP1
13.05 – 13.10 Ozan KAYAR, OP2
13.10 – 13.15 Elif Keleş GÜLNERMAN, OP3
13.15 – 13.20 Zahide Mail GÜRKAN, OP4
13.20 – 13.25 Aylin REYHANİ, OP5
13.25 – 13.30 Belgin MUTLUAY, OP6
13.30 – 13.35 Buse Çağla ARI, OP7
13.35 – 14.00 Discussion
14.00 – 15.00 Satellite
Women & Migraine: What We Need To Know?
Moderatör : Prof. Dr. Aynur Özge
Prof. Dr. Elif Ilgaz Aydınlar
15.00 – 16.30 How To Manage A Challenging Case With Migraine
Zaza KATSARAVA, Paolo MARTELLETTI
15.00 – 15.15 Diagnostic Gap In Migraine
Zaza KATSARAVA
15.15 – 15.30 Management Gap In Migraine
Dimos MITSIKOSTAS
15.30 – 15.45 Improving Quality Of Life In Migraine – Biopsychosocial Approach
Simona SACCO
15.45 – 16.30 Discussion
Rigmor JENSEN, Najib KISSANI
16.30 – 17.30 Oral Presentations
Macit SELEKLER, Parvin ALLAHYAROVA
16.30 – 16.35 Ece YANIK, OP8
16.35 – 16.40 Kadir Oğuzhan SOYLU, OP9
16.40 – 16.45 Suna Aşkın TURAN, OP10
16.45 – 16.50 Somayeh Nasergivehchi, OP11
16.50 – 16.55 Naci Emre AKŞEHİRLİ, OP12
16.55 – 17.00 Ceren ALİŞ, OP13
17.00 – 17.05 Eren TOPLUTAŞ, OP14
17.05 – 17.30 Discussion
09.30 – 11.00 Intracranial Pressure Changes Headaches
Derya ULUDÜZ – Neşe ÇELEBİSOY
09.30 – 09.45 Diagnostic Gap in IPC Headaches
Henrik SCHYTZ
09.45 – 10.00 Management Gap in IPC Headaches
Neşe ÇELEBİSOY
10.00– 10.15 Challenging Cases In Chronic Daily Headache
Kirill SKOROBOGATYKH
10.15 – 11.00 Discussion
Mansoureh TOGHA, Stefan EVERS
11.00 – 11.30 Coffee Break
11.30 – 13.00 Trigeminal Autonomic Cephalalgias
Peter GOADSBY, Esme EKİZOĞLU
11.30 – 11.45 Footprints Of TACs
Arne MAY
11.45 – 12.00 Coping With TACs In Emergency Room Settings
Esme EKİZOĞLU
12.00 – 12.15 Coping With TACs In Outpatient
Pınar Yalınay DİKMEN
12.15 – 13.00 Discussion
Necdet KARLI, Massimo LEONE
13.00 – 14.00 Oral Presentations
Esra Acıman DEMİREL, Bilgin ÖZTÜRK
13.00 – 13.05 Ayşe Nur Özdağ ACARLI, OP15
13.05 – 13.10 Murat GÜLTEKİN, OP16
13.10 – 13.15 Nevra ÖKSÜZ, OP17
13.15 – 13.20 Yonca ÜNLÜBAŞ, OP18
13.20 – 13.25 Aslıhan TAŞKIRAN, OP19
13.25 – 13.30 Rahşan KARACI, OP20
13.30 – 13.35 Şenay Yıldız ÇELİK, OP21
13.35 – 14.00 Discussion
14.00 – 15.00 Satellite
Galcanezumab In Migraine Prevention
Moderatör : Aynur ÖZGE
Christian Lampl
Necdet Karlı
15.00 – 17.00 Debate On Headaches Part–1 (15 min. presentation per speaker + 5 min discussion)
Mi Ji LEE, Alan RAPOPORT
15.00 – 15.40 Persistent Idiopathic Facial Pain – Is A Specific Entity?
Pro: Sait ASHINA Con: Hossein ANSARI
15.40 – 16.20 Monoclonal antibodies – Safe For Everyone?
Pro: Lars EDVINSSON Con: Faisal Mohammad AMIN
16.20 – 17.00 Novel Therapies In Pediatric Migraine – Is Reliable?
Pro: Andrew HERSHEY Con: Amy GELFAND
17.00 – 18.00 Oral Presentations
Callixte KUATE, Samiye ULUTAŞ
17.00 – 17.05 Yağmur KARAMAN, OP22
17.05 – 17.10 Yalçın HACIOĞLU, OP23
17.10 – 17.15 İrem Hacısalihoğlu AYDIN, OP24
17.15 – 17.20 Berkan KAPLAN, OP25
17.20 – 17.25 Semih TAŞDELEN, OP26
17.25 – 17.30 Güneş Altıokka UZUN, OP27
17.30 – 17.35 Burcu POLAT, OP28
17.35 – 18.00 Discussion
08.30 – 09.20 Turkic Linguistic Special Interest Group Session – Case Presentations
(5 Cases: 8 min. Presentation + 2 min. Discussion for each Case)
Esme Ekizoğlu, Parvin Allahyarova
09.20– 09.30 Coffee Break
09.30 – 11.35 Interventional Management In Headaches
Aynur ÖZGE, Gül Köknel TALU
09.30 – 09.45 Peripheral Nerve Blocks
Işın Ünal ÇEVİK
09.45 – 10.00 Trigger Point Injections And Dry Needle
Didem AKÇALI
10.00 – 10.15 Ganglion Blocks
Meltem UYAR
10.15 – 10.35 Real Life Experience About Botox In Migraine?
Fayyaz AHMED
10.35 – 10.50 Botulinum Toxin Injections
Tuğba TUNÇ
10.50 – 11.05 Peripheral Nerve Stimulations
Süleyman ÖZYALÇIN
11.05 – 11.35 Discussion
Hossein ANSARI, Derya ULUDÜZ
11.35 – 11.50 Coffee Break
11.50 – 13.20 Headache In Special Groups
Ishaq Abu ARAFEH, Işın Ünal ÇEVİK
11.50 – 12.05 Is Childhood Migraine A Miniature Version Of Adult Migraine?
Ishaq Abu ARAFEH
12.05 – 12.20 How Will I Manage Elderly Headache?
Füsun Mayda DOMAÇ
12.20 – 12.35 A Dilemma To Manage Headache During Pregnancy And Puerperium
Elif Kocasoy ORHAN
12.35 – 13.20 Discussion
Vincenzo GUIDETTI, Miguel LAINEZ
13.20 – 14.20 Oral Presentations
Halil ÇETİNGÖK, Rahşan KARACI
13.20 – 13.25 Nesrin ERGİN, OP29
13.25 – 13.30 Rabia Gökçen Gözübatık ÇELİK, OP30
13.30 – 13.35 Emel Ur ÖZÇELİK, OP31
13.35 – 13.40 Hacı Ali ERDOĞAN, OP32
13.40 – 13.45 Zerrin YILDIRIM, OP33
13.45 – 13.50 Hatice Reyhan ÖZGÖBEK, OP34
13.50 – 13.55 İbrahim ACIR, OP35
13.55 – 14.20 Discussion
14.20 – 16.20 Debate On Headaches Part–2 (15 min presentation per speaker + 5 min discussion)
Otgonbayar LUVSANNOROV,Najib KISSANI
14.20 – 15.00 CSD Is A Key Trigger For Migraine Headache Attacks
Pro: Hülya KARATAŞ KURŞUN Con: Hayrunnisa Bolay
15.00 – 15.40 Healthy Microbiata Is Essential In Migraine?
Pro: Mansoureh TOGHA Con: Doğa VURALLI
15.40 – 16.20 Vestibular Migraine Is A Specific Entity
Pro: Gülden AKDAL Con: Michael HALMAGYI
16.20 – 17.20 Oral Presentations
Krishna Kumar OLI, Devrimsel Harika ERTEM
16.20 – 16.25 Lerze Furkan YAGHOUTI, OP36
16.25 – 16.30 Oneda ÇİBUKU, OP37
16.30 – 16.35 Kjenda ELPENORIA, OP38
16.35 – 16.40 Mustafa KURÇALOĞLU, OP39
16.40 – 16.45 Buse Çağla ARI, OP40
16.45 – 16.50 Hasan Armağan UYSAL, OP41
16.50 – 17.20 Discussion
17.20 – 17.50 Closing Remarks